BGI Health Forms Partnership to Serve MENA Region
Nov 08 2013 Read 1163 Times
BGI-Health, a subsidiary sequencing application unit of BGI, has signed a Memorandum of Understanding with Sidra Medical and Research Centre to bring genomics technology and population studies to Middle Eastern and North African countries (MENA).
The partnership provides for direct engagement and coordination between BGI Health and Sidra on genomics, research and development. Collaboration will focus on reproductive health, new born screening, autism, hereditary cancer, monogenic disorders, and exome sequence-based personalised medical healthcare. Additionally, BGI Health will provide genetic testing to meet the demands of Sidra and the MENA region, namely, pre-marital, pre-conception, pre-implantation, pre-natal and pre-school testing for a large number of genes relevant to disease. BGI Health will be the first organisation to offer clinically genetic testing by NGS technology in Qatar.
Dr. Jingxiang Li, Chief Executive Officer of BGI Asia-Pacific said: “We’re delighted to embark on this partnership with Sidra, and to jointly establish a genomic center of excellence with emphasis on the clinical applications of NGS. An integration of BGI’s expertise on sequencing and bioinformatics, along with Sidra’s pioneering clinical and translational research, will lead to exciting prospects in the development of genomic translational medicine and personalised health care.”
Dr. William F. Owen Jr, Chief Executive Officer of Sidra said: “It is a major milestone for Sidra to partner with BGI Health, an established, world-class genomics leader. This agreement will facilitate routine, interactive relationships between Sidra and other local scientists in research and development. Obviously, this will bring important benefits to the people of Qatar and the wider region through cutting-edge genomics and R&D.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Meet. Learn. Discover - Ways to tackle the spread of coronavirus using viricidal surface decontamination Features Chromatography - New Wettable Phase Thri...
View all digital editions
Mar 29 2020 Palm Springs, CA, USA
Mar 31 2020 Edinburgh, UK
Apr 07 2020 Cairo, Egypt
Apr 13 2020 Casablanca, Morocco
Apr 26 2020 Montreal, Quebec, Canada